OMIDRIAHCP.COM: Keyword Density Checker

Total words: 2105 | 2-word phrases: 553 | 3-word phrases: 595 | 4-word phrases: 610

PAGE INFO

Title	Try to keep the title under 60 characters (62 characters) OMIDRIA® (phenylephrine and ketorolac) \| Official HCP Website
Description	Try to keep the meta description between 50 - 160 characters (174 characters) See if FDA-approved OMIDRIA, a non-opioid analgesic and NSAID treatment, is right for your patients during cataract surgeries. Please see the ISI and full PI on this website.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

ONE WORD PHRASES 347 Words

#	Keyword	Frequency	Density
1	to	32	9.22%
2	and	27	7.78%
3	omidria	22	6.34%
4	of	19	5.48%
5	the	19	5.48%
6	cataract	14	4.03%
7	in	12	3.46%
8	or	11	3.17%
9	with	10	2.88%
10	for	10	2.88%

TWO WORD PHRASES 553 Words

#	Keyword	Frequency	Density
1	cataract surgery	8	1.45%
2	added to	5	0.90%
3	safety information	5	0.90%
4	use omidria	5	0.90%
5	irrigating solution	5	0.90%
6	cataract refract	4	0.72%
7	see the	4	0.72%
8	of a	4	0.72%
9	intraoperative miosis	4	0.72%
10	in patients	4	0.72%
11	full prescribing	4	0.72%
12	important safety	4	0.72%
13	you are	4	0.72%
14	and is	4	0.72%
15	with a	4	0.72%
16	capsule opacification	3	0.54%
17	posterior capsule	3	0.54%
18	eye irritation	3	0.54%
19	are eye	3	0.54%
20	the most	3	0.54%

THREE WORD PHRASES 595 Words

#	Keyword	Frequency	Density
1	important safety information	4	0.67%
2	in patients with	3	0.50%
3	other nonsteroidal antiinflammatory	3	0.50%
4	medical history of	3	0.50%
5	a past medical	3	0.50%
6	have a past	3	0.50%
7	or have a	3	0.50%
8	nsaids or have	3	0.50%
9	drugs nsaids or	3	0.50%
10	and other nonsteroidal	3	0.50%
11	of asthma the	3	0.50%
12	derivatives and other	3	0.50%
13	acid derivatives and	3	0.50%
14	phenylacetic acid derivatives	3	0.50%
15	to acetylsalicylic acid	3	0.50%
16	sensitivities to acetylsalicylic	3	0.50%
17	exhibited sensitivities to	3	0.50%
18	previously exhibited sensitivities	3	0.50%
19	history of asthma	3	0.50%
20	asthma the most	3	0.50%
21	who have previously	3	0.50%
22	capsule opacification increased	3	0.50%
23	inflammation please see	3	0.50%
24	chamber inflammation please	3	0.50%
25	anterior chamber inflammation	3	0.50%
26	intraocular pressure and	3	0.50%
27	increased intraocular pressure	3	0.50%
28	opacification increased intraocular	3	0.50%
29	posterior capsule opacification	3	0.50%
30	commonly reported adverse	3	0.50%

FOUR WORD PHRASES 610 Words

#	Keyword	Frequency	Density
1	and other nonsteroidal antiinflammatory	3	0.49%
2	please see the full	3	0.49%
3	at ≥ 2 are	3	0.49%
4	≥ 2 are eye	3	0.49%
5	2 are eye irritation	3	0.49%
6	posterior capsule opacification increased	3	0.49%
7	capsule opacification increased intraocular	3	0.49%
8	opacification increased intraocular pressure	3	0.49%
9	increased intraocular pressure and	3	0.49%
10	anterior chamber inflammation please	3	0.49%
11	chamber inflammation please see	3	0.49%
12	inflammation please see the	3	0.49%
13	see the full prescribing	3	0.49%
14	adverse reactions at ≥	3	0.49%
15	information for omidria you	3	0.49%
16	for omidria you are	3	0.49%
17	omidria you are encouraged	3	0.49%
18	you are encouraged to	3	0.49%
19	are encouraged to report	3	0.49%
20	encouraged to report suspected	3	0.49%
21	to report suspected adverse	3	0.49%
22	reactions to the fda	3	0.49%
23	to the fda visit	3	0.49%
24	the fda visit wwwfdagovmedwatch	3	0.49%
25	reactions at ≥ 2	3	0.49%
26	reported adverse reactions at	3	0.49%
27	visit wwwfdagovmedwatch or call	3	0.49%
28	acid derivatives and other	3	0.49%
29	pressure use omidria with	3	0.49%
30	use omidria with caution	3	0.49%
31	omidria with caution in	3	0.49%
32	with caution in individuals	3	0.49%
33	who have previously exhibited	3	0.49%
34	have previously exhibited sensitivities	3	0.49%
35	previously exhibited sensitivities to	3	0.49%
36	exhibited sensitivities to acetylsalicylic	3	0.49%
37	sensitivities to acetylsalicylic acid	3	0.49%
38	phenylacetic acid derivatives and	3	0.49%
39	derivatives and other nonsteroidal	3	0.49%
40	commonly reported adverse reactions	3	0.49%

EXTERNAL LINKS

#	URL	Whois	Check
1	https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program	Whois	fda.gov
2	https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program	Whois	fda.gov
3	https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program	Whois	fda.gov

OMIDRIAHCP.COM KEYWORD DENSITY CHECKER

PAGE INFO

ONE WORD PHRASES 347 Words

TWO WORD PHRASES 553 Words

THREE WORD PHRASES 595 Words

FOUR WORD PHRASES 610 Words

EXTERNAL LINKS

Email Tools

Website Tools

OMIDRIAHCP.COM KEYWORD DENSITY CHECKER

PAGE INFO

ONE WORD PHRASES 347 Words

TWO WORD PHRASES 553 Words

THREE WORD PHRASES 595 Words

FOUR WORD PHRASES 610 Words

EXTERNAL LINKS

Email Tools

Website Tools

Modal Heading